AstraZeneca Pharma India Limited — Important, 13-11-2024: General Updates

The Board of Directors has approved the appointment of Mr. Jesus Javier Diaz Ropero Esteso as an Additional Director (Non-Executive). Mr. Esteso brings over two decades of financial expertise, having held strategic roles at AstraZeneca, including VP Finance and CFO for International Markets. He has a strong focus on finance transformation and has contributed to significant financial improvements in various leadership positions. His experience extends to roles at The Coca-Cola Company and consulting firms such as PWC and EY. This appointment may enhance AstraZeneca's strategic financial direction, given Mr. Esteso's extensive background and proven track record in driving financial performance. Investors should consider this leadership addition positively as it may bolster the company's growth potential.